A randomized clinical trial involving 200 adults with obesity in Brazil’s public health care system has raised a familiar but difficult question in weight-management research: Can lifestyle programs delivered through a blend of in-person and remote care produce meaningful weight loss outside highly controlled specialist settings? The answer from the trial’s primary analysis was not encouraging. Participants assigned to the hybrid intervention were no more likely than those in the comparison group to achieve at least 5% weight loss, a benchmark commonly used to indicate clinically meaningful improvement.
The findings, published in JAMA Network Open, are important because they test a model designed to extend lifestyle treatment beyond traditional clinic visits. Hybrid interventions have attracted growing interest as health systems attempt to combine professional guidance with digital communication, remote monitoring, and flexible participation. Such programs may reduce travel and scheduling barriers, but their effectiveness depends heavily on whether participants remain engaged over time.
The study used randomization, a method intended to create comparable groups at the beginning of a trial and reduce the influence of confounding factors. Its primary outcome was assessed using an intention-to-treat analysis. In this approach, participants are analyzed according to the group to which they were originally assigned, regardless of how consistently they attended sessions or followed the prescribed program. This strategy preserves the benefits of randomization and provides a pragmatic estimate of what might happen when an intervention is offered in real-world care.
Under that analysis, the hybrid lifestyle intervention did not significantly increase the likelihood that participants would lose at least 5% of their initial body weight. The result suggests that simply making lifestyle support available in a blended format may not be sufficient to produce substantial weight loss across an entire treatment population. It also highlights the difference between the potential efficacy of a program for highly engaged participants and its effectiveness when delivered to everyone who is eligible.
The researchers also conducted secondary and per-protocol analyses. Secondary analyses examine outcomes beyond the main question, while per-protocol analyses focus on participants who adhered more closely to the intervention. These analyses suggested that participants who remained engaged may have experienced improvements in cardiometabolic health, even though the intervention did not achieve its primary weight-loss target in the intention-to-treat population.
Cardiometabolic health encompasses biological measures linked to the risk of conditions such as type 2 diabetes, cardiovascular disease, and hypertension. Improvements in these measures can occur even when changes on the scale are modest. Physical activity, dietary changes, improved sleep, and reductions in abdominal fat may influence metabolic regulation and cardiovascular risk before they produce large changes in total body weight. However, because per-protocol groups are defined by adherence after randomization, they may differ from less-adherent participants in motivation, health status, resources, or other factors. Those differences can make it difficult to determine whether the intervention itself caused the apparent benefits.
This distinction is particularly relevant in obesity research, where adherence is often one of the strongest determinants of outcome. Participants may face economic pressures, limited access to healthy food, transportation difficulties, unstable work schedules, and competing health needs. These challenges can affect both participation in a program and the ability to sustain behavioral changes. A treatment that works among those who can attend regularly may therefore have a smaller overall impact when implemented across a public health system serving a diverse population.
The Brazilian setting gives the findings additional significance. Public health services must balance clinical ambition with limited staff, time, infrastructure, and funding. Hybrid care could potentially expand access, but digital or partially remote treatment may also introduce new barriers, including inadequate internet access, low digital literacy, and difficulty maintaining personal contact with health professionals. The trial’s results suggest that future programs may need more intensive engagement strategies, tailored support, or additional clinical tools rather than relying on delivery format alone.
The authors, led by Graziele Souza de Menezes Amorim Coelho of São Paulo, indicate that the cardiometabolic signals seen among adherent participants warrant further investigation. Larger studies could clarify which patients benefit most, which components of the intervention drive change, and whether improvements persist after structured support ends. Researchers will also need to determine how adherence can be strengthened without making programs too costly or difficult to deliver. For now, the trial offers a nuanced message: a hybrid lifestyle intervention did not improve the primary weight-loss outcome for the population as a whole, but sustained participation may still hold promise for improving health beyond the number on the scale.
Subject of Research: Hybrid lifestyle intervention for obesity and cardiometabolic health in adults receiving care through Brazil’s public health care system
Web References: https://doi.org/10.1001/jamanetworkopen.2026.26884
References: Coelho, Graziele Souza de Menezes Amorim, et al. JAMA Network Open. doi:10.1001/jamanetworkopen.2026.26884
Keywords: Obesity, metabolic health, adults, medical treatments, data analysis, public health, health care, randomization, disease intervention, clinical trials, weight loss, cardiology
